Abstract:The wide array of polydimethylsiloxane (PDMS) variants available on the market, coupled with the intricate combination of additives in silicone polymers, and the incomplete understanding of drug release behavior make formulation development of levonorgestrel intrauterine systems (LNG-IUSs) formidable. Accordingly, the objectives of this work were to investigate the impact of excipients on formulation attributes and in vitro performance of LNG-IUSs, elucidate drug release mechanisms, and thereby improve product understanding. LNG-IUSs with a wide range of additives and fillers were prepared, and in vitro drug release testing was conducted for up to 12 months. Incorporating various additives and/or fillers (silica, silicone resins, silicone oil, PEG, etc.) altered the crystallization kinetics of the crosslinked polymer, the viscosity, and the microstructure. In addition, drug-excipient interactions can occur. Interestingly, additives which increased matrix hydrophobicity and hindered PDMS crystallization facilitated dissolution and permeation of the lipophilic LNG. The influence of additives and lubricants on the mechanical properties of LNG-IUSs were also evaluated. PDMS chemical substitution and molecular weight were deemed to be most critical polymer attributes to the in vitro performance of LNG-IUSs. Drugs with varying physicochemical characteristics were used to prepare IUSs, modeling of the release kinetics was performed, and correlations between release properties and the various physicochemical attributes of the model drugs were established. Strong correlations between first order release rate constants and both drug solubility and Log P underpin the partition and diffusion-based release mechanisms in LNG-IUSs. This is the first comprehensive report to provide a mechanistic understanding of material-property-performance relationships for IUSs. This work offers an evidence-based approach to rational excipient selection and tailoring of drug release to achieve target daily release rates in vivo. The novel insights gained through this research could be helpful for supporting development of brand and generic IUS products as well as their regulatory assessment.

Synchronic Release Of Two Hormonal Contraceptives For About One Month From The Plga Microspheres: In Vitro And In Vivo Studies

An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics

Controlled Release of Levonorgestrel from Biodegradable Poly(d,l-Lactide-co-glycolide) Microspheres: in Vitro and in Vivo Studies.

Preparation and Characterization of Hcg-Loaded Polylactide or Poly(lactide-Co-glycolide) Microspheres Using a Modified Water-in-oil-in-water (w/o/w) Emulsion Solvent Evaporation Technique

[Preparation, Characterization and Drug Release Characteristics of Poly(lactide)(pl)/poly(lactide-Co-polyethylene Glycol)(pleg) Blend Microspheres].

Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives

A biodegradable long-term contraceptive implant with steady levonorgestrel release based on PLGA microspheres embedded in PCL-coated implant

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

In vitro and in vivo investigation of a novel two-phase delivery system of 2-methoxyestradiol liposomes hydrogel

Preparation and in Vivo Pharmacokinetics of Rhgh-Loaded PLGA Microspheres.

Tailoring drug release from long-acting contraceptive levonorgestrel intrauterine systems

Effect of drug encapsulation and sterilization process on physicochemical properties and release of combined steroid hormones from poly (ε-caprolactone) fibers

Exploring Trehalose on the Release of Levonorgestrel from Implantable PLGA Microneedles

The Effect of Polymer Blends on the In Vitro Release/Degradation and Pharmacokinetics of Moxidectin-Loaded PLGA Microspheres

781-P: Sustained-Release Formulation Development and Preclinical Evaluations of Monthly or Bimonthly Injectable Semaglutide and Tirzepatide

Development of a novel 3-month drug releasing risperidone microspheres

Biodegradable block copolymer matrices for long-acting contraceptives with constant release

Preparation and in vitro evaluation of risperidone loaded PLGA microspheres